CASE STUDY

Reshaping the future of
biopharmaceutical
manufacturing

with powered ADMAlyticsTM!

Download Case Study
Fill out the form to access your copy and embark on a transformative experience!
Our case study delves into the remarkable transformation brought about by ADMAlyticsTM, an AI-powered platform developed by tcgmcubeTM, within the operations of ADMA Biologics, a key player in plasma derived therapeutics. Discover how our platform has propelled ADMA Biologics towards manufacturing excellence, improving product margin and overall market capitalization.

In biopharma, innovation is not just desired, it's essential! TCG Digital recognizes this urgency and leverages its FedRAMP certified end-to-end AI platform, tcgmcubeTM to engineer the cutting-edge platform, ADMAlyticsTM for ADMA Biologics. This collaboration is not merely about streamlining processes; it's about catalysing a cultural shift toward data-driven decision making leading to continuous improvement and innovation.

Key highlights from the case study

  • Predicting batch yield to increase profitability
  • Optimized raw material usage – Optimizing high value plasma usage while maintaining consistent batch yields
  • Real time monitoring and improvement of operations KPI - leading to better margins
  • Gen AI based enterprise search - tcgmcubeTM local LLM trained on specialized life sciences data, applying semantic modeling, and FAIRification to enhance productivity in enterprise search!

Download the case study to explore how tcgmcubeTM powered ADMAlyticsTM is driving manufacturing excellence, enhancing data accessibility, and empowering real-time decision-making at ADMA Biologics.